Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
ILA-H5269 | Human | Human IL-5 R alpha / CD125 Protein, Fc Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
ILA-H52H4 | Human | Human IL-5 R alpha / CD125 Protein, His Tag | ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Benralizumab | BIW-8405; KHK-4563; MEDI-563; BIW-8405-IL-5R | Approved | Biowa Inc, Medimmune Llc | Fasenra | Japan | Asthma | Astrazeneca Pharmaceutical Co Ltd | 2017-11-14 | Bronchiectasis; Gastroenteritis; Hypersensitivity; Eczema; Dermatitis, Atopic; Skin Diseases, Genetic; Hypersensitivity, Immediate; Pulmonary Disease, Chronic Obstructive; Sinusitis; Leukocyte Disorders; Asthma; Pemphigoid, Bullous; Eosinophilic Esophagitis; Eosinophilic gastroenteritis (EG); Immune System Diseases; Skin Diseases, Eczematous; Dermatitis; Skin Diseases; Genetic Diseases, Inborn; Nasal Polyps; Eosinophilia; Respiratory Tract Diseases; Chronic Urticaria; Asthma, Exercise-Induced; Hematologic Diseases; Hypereosinophilic Syndrome | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
CSL-311 | CSL-311 | Csl Ltd | Details |
This web search service is supported by Google Inc.